Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions
Oesophageal Cancer
Interventions
DEVICE

Cytosponge™

Cytosponge™ is a capsule-sized device which contains an expandable, spherical mesh which is attached to a string. The capsule dissolves in the stomach after swallowing, releasing the sponge which is then retrieved by gently pulling the string after five minutes. As the sponge is pulled out it collects the cells from the lining of the gullet.

Trial Locations (11)

Unknown

Glan Clwyd hospital, Bodelwyddan

Cancer Institute Bristol, Bristol

Addenbrooke's Hospital, Cambridge

Velindre Cancer Centre, Cardiff

Castle Hill hospital, Hull

Leicester General hospital, Leicester

The Christie, Manchester

Clatterbridge hospital, Metropolitan Borough of Wirral

Milton Keynes University Hospital, Milton Keynes

Churchill hospital, Oxford

University Hospital Southampton, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centre for Statistics in Medicine

OTHER

collaborator

Cancer Research UK

OTHER

collaborator

University of Cambridge

OTHER

collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

lead

University of Oxford

OTHER

NCT03529669 - Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer | Biotech Hunter | Biotech Hunter